Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Patent
1995-06-06
1998-06-23
Tsang, Cecilia
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
514 12, A67K 3816
Patent
active
057706883
ABSTRACT:
A method and composition are described for the treatment of mammalian HIV infections including administering an effective subtoxic dosage of melittin (Seq. ID NO:1) to the mammal whereby the growth of HIV infected cells or the replication of the virus in the infected cells of the mammal is inhibited.
REFERENCES:
patent: 4822608 (1989-04-01), Benton
Egberink et al., Suppression of Feline Immunodeficiency Virus Infection in vivo by 9-(2-phosphonomethoxyethyl)adenine, Proc. natl. Acad. Sci. USA, vol. 87, 3087-3091, 3087 (1990).
Kindt et al, Animal Models for Acquired Immunodeficiency Syndrome, Advances in Immunology, vol. 52, 425-474, 441 (1992).
Mellors, John W., Closing in on Human Immunodeficiency Virus-1, Nature Medicine, vol. 2, No. 3, 274-275 (1996).
Bendinelli et al. 1995. Feline Immunodeficiency Virus: A Interesting Model for Aids Studies & An Important Cat Pathogen. Clin Microbiol. Rev. 8(1):pp. 87-112.
H. Andreassen et al., "Analysis of the Secondary Structure of the Human Immunodeficiency Virus (HIV) Proteins p17, gp120, and gp41 by Computer Modeling Based on Neutral Network Methods," Journal of Acquired Immune Deficiency Syndromes, v. 3 (1990), pp. 615-622.
A. Argiolas et al., "Bombolitins, a New Class of Mast Cell Degranulating Peptides from the Venom of the Bumblebee Megabombus pennsylvanicus," The Journal of Biological Chemistry, v. 260, No. 3 (Feb. 10, 1985), pp. 1437-1444.
A. W. Bernheimer et al., "Interactions between membranes and cytolytic peptides," Biochimica et Biophysica Acta, v. ;864 (1986), pp. 123-141.
L. R. Boone et al., "Viral DNA Synthesized In Vitro by Avian Retrovirus Particles Permeabilized with Melittin," Journal of Virology, v. 37, No. 1 (Jan. 1918), pp. 109-116.
A. F. Esser et al., "Disassembly of viral membranes by complement independent of channel formation," Proc. Natl. Acad. Sci. USA, v. 76, No. 11 (Nov. 1979), pp. 5843-5847.
E. T. Kaiser et al., "Amphiphilic Secondary Structure: Design of Peptide Hormones," Science, v. 223 (20 Jan. 1984), pp. 249-255.
E. T. Kasier et al., "Secondary structures of proteins and peptides in amphiphilic environments (A Review)," Proc. Natl. Acad. Sci. USA, v. 80 (Feb. 1983), pp. 1137-1143.
K. Lubke et al., "Haemolytic Activity and Action on the Surface Tension of Aqueous Solutions of Synthetic Melittins and their Derivatives," Experentia, v. 27, No. 7 (1971), pp. 764-767.
W. Mellert et al., "HTLV-III/LAV--Antikorpertest: Indirekte Immunperoxidasefarbung (HILV-III/LAV antibody test: Indirect Immunoperoxidase staining)," AIDS--For Schung (AIFO) Feb. 1986 Heft 2, pp. 105-107.
W. Mellert et al., "Infection of human fibroblasts and osteoblast-like cells with HIV-1", AIDS, v. 4, No. 6 (1990), pp. 527-535.
T. Mosmann, "Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays," Journal of Immunological Methods, v. 65 (1983), pp. 55-63.
T. Saermark et al., "Acylation of HIV proteins," Biochemical Society Transactions, v. 17 (1989), pp. 869-871.
Wachinger et al. FEBS vol. 309(3) 235-241.
ASM News vol. 56 No. 7 Jul. 1990.
Richman et al., J. of Virology, vol. 68, No. 3, Mar. 1994 pp. 1660-1666.
Saag et al., J. of Acquired Immune Deficiency Syndromes, F. Suppl. 2, S2-S11. (1994).
Carosi, AIDS, (1994) vol. 8, (Suppl. 3) S1-S2.
Leff, BioWorld Today, (Oct. 18, 1994) vol. 5, No. 210, pp. 1 & 5.
D. J. Witt et al., "Phosphorylation of Vesicular Stomatitis Virus Proteins as a Possible Contributing Factor in Virion Uncoating," J. gen. Virol., v. 56 (1981), pp. 383-391.
The Declaration of Release relates to the deposit of human mesenchymal cell line LC5 and LC5-HIV which were deposited with the German Patent Office and given accession No. I842 and I843 on Mar. 9, 1989. These cell lines were first mentioned in German Patent Application No. P 3916251.6.
The formulation of RPMI 1640 is set forth therein. RMPI 1640 is the culture upon which cell line LC5 and LC5-HIV were grown.
The Biomek 1000 advertisement relates to an automated laboratory workstation manufactured by Beckman Instruments and which was employed in the studies discussed in the present case.
Erfle Volker
Saermark Torben
GSF-Forschungszentrum fur Umwelt und Gesundheit GmbH
Gupta Anish
Tsang Cecilia
LandOfFree
Method and composition for the treatment of mammalian HIV infect does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for the treatment of mammalian HIV infect, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for the treatment of mammalian HIV infect will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1395428